In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

Immunotherapy with PD-1 checkpoint blockade is effective in only a minority of patients with cancer, suggesting that additional treatment strategies are needed. Here we use a pooled in vivo genetic screening approach using CRISPR–Cas9 genome editing in transplantable tumours in mice treated with imm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nature
Main Authors: Manguso, Robert T., Pope, Hans W., Zimmer, Margaret D., Brown, Flavian D., Yates, Kathleen B., Miller, Brian C., Collins, Natalie B., Bi, Kevin, LaFleur, Martin W., Juneja, Vikram R., Weiss, Sarah A., Lo, Jennifer, Fisher, David E., Miao, Diana, Van Allen, Eliezer, Root, David E., Sharpe, Arlene H., Doench, John G., Haining, W. Nicholas
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5924693/
https://ncbi.nlm.nih.gov/pubmed/28723893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature23270
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados